Advertisement

Ads Placeholder
Loading...

UCB SA

UCBJYPNK
Healthcare
Biotechnology
$159.36
$3.33(2.13%)
U.S. Market opens in 5h 0m

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap60.7B
P/E Ratio33.41
EPS (TTM)$4.65
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$125.82
3 Months$158.02
1 Year Target$179.52

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.41 and a market capitalization of 60.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.13%
5-Day Change
2.55%
1-Month Change
5.74%
3-Month Change
7.52%
6-Month Change
6.17%
Year-to-Date (YTD) Change
16.00%
1-Year Change
108.26%
3-Year Change
243.005%
5-Year Change
231.10%
All-Time (Max) Change
962.40%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

90,520 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions